LMAT director granted dividend equivalent rights

LEMAITRE VASCULAR INC director Lawrence J. Jasinski reported routine compensation-related grants of dividend equivalent rights.

Rhea-AI Filing Summary

LEMAITRE VASCULAR INC director Lawrence J. Jasinski reported routine compensation-related grants of dividend equivalent rights. On March 26, 2026, he acquired several small fractional awards of dividend equivalent rights linked to existing restricted stock unit and performance share unit grants from December 8, 2023, December 6, 2024, and December 10, 2025. Each dividend equivalent right is the economic equivalent of one share of LeMaitre Vascular common stock and will vest proportionately with the underlying stock or performance awards. These are non-cash, derivative awards and do not represent any open-market share purchases or sales.

Insider Trade Summary

Grant/Award: 3.444 shares

Grant/Award 5 txns

Insider Jasinski Lawrence J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights	0.3941	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	0.472	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	0.6426	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	0.7276	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights	1.2077	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 17.2834 contracts (Direct)

Footnotes (5)

1. F1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
2. F2. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
3. F3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
4. F4. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
5. F5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Dividend Equivalent Rights grant: 0.3941 rights Dividend Equivalent Rights grant: 0.4720 rights Dividend Equivalent Rights grant: 0.6426 rights +4 more

7 metrics

Dividend Equivalent Rights grant 0.3941 rights Granted on March 26, 2026, economic equivalent of common stock

Dividend Equivalent Rights grant 0.4720 rights Granted on March 26, 2026, tied to prior equity award

Dividend Equivalent Rights grant 0.6426 rights Granted on March 26, 2026 as derivative compensation

Dividend Equivalent Rights grant 0.7276 rights Granted on March 26, 2026, vests with underlying award

Dividend Equivalent Rights grant 1.2077 rights Granted on March 26, 2026, economic equivalent of shares

Transactions acquiring rights 5 derivative entries All coded A for grant/award on March 26, 2026

Net buy/sell shares 0 shares transactionSummary netBuySellShares neutral in this Form 4

Key Terms

Dividend Equivalent Rights, restricted stock unit, performance share unit, economic equivalent, +1 more

5 terms

Dividend Equivalent Rights financial

"These dividend equivalent rights accrued on a restricted stock unit award"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock unit financial

"accrued on a restricted stock unit award granted on 12/8/2023"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

performance share unit financial

"accrued on a performance share unit award granted on 12/8/2023"

A performance share unit (PSU) is a form of executive or employee pay that promises shares (or the cash value of shares) only if the company meets specific performance targets over a set period. Think of it like a bonus cheque that only arrives if the company hits agreed goals — it aligns managers’ rewards with business results and signals to investors how leadership is being incentivized to grow value over time.

economic equivalent financial

"Each dividend equivalent right is the economic equivalent of one share"

derivative financial

"transaction_type": "derivative""

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LMAT director Lawrence Jasinski report?

Lawrence J. Jasinski reported acquiring several small grants of Dividend Equivalent Rights on March 26, 2026. These awards are tied to prior restricted stock unit and performance share unit grants and are part of his equity-based director compensation, not market purchases or sales.

What are Dividend Equivalent Rights in the LMAT Form 4 filing?

Dividend Equivalent Rights give the holder economic value similar to LMAT common stock dividends. In this filing, each right is the economic equivalent of one common share and accrues on existing restricted stock unit and performance share unit awards, vesting proportionately with those underlying grants over time.

Were any LMAT common shares bought or sold in this Form 4?

No LMAT common shares were bought or sold in this Form 4. The reported transactions involve derivative compensation awards (Dividend Equivalent Rights) credited at a price of $0.0000 per right, reflecting routine equity-based compensation rather than open-market trading activity.

Which prior LMAT equity awards generated these Dividend Equivalent Rights?

The Dividend Equivalent Rights accrued on LMAT awards granted on December 8, 2023, December 6, 2024, and December 10, 2025. They are linked to both restricted stock unit and performance share unit grants and will vest in step with those underlying awards as they vest.

How many Dividend Equivalent Rights did Jasinski acquire in each LMAT grant?

Jasinski acquired fractional amounts of Dividend Equivalent Rights in several grants, including 0.3941, 0.4720, 0.6426, 0.7276, and 1.2077 rights. Each fractional right corresponds economically to the same fraction of a share of LMAT common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/30/2026 - 05:58 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jasinski Lawrence J

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	03/26/2026		A		0.3941		(1)	(1)	Common Stock	0.3941	$0	4.6016	D
Dividend Equivalent Rights	(2)	03/26/2026		A		0.472		(2)	(2)	Common Stock	0.472	$0	4.3113	D
Dividend Equivalent Rights	(3)	03/26/2026		A		0.6426		(3)	(3)	Common Stock	0.6426	$0	3.5389	D
Dividend Equivalent Rights	(4)	03/26/2026		A		0.7276		(4)	(4)	Common Stock	0.7276	$0	3.6239	D
Dividend Equivalent Rights	(5)	03/26/2026		A		1.2077		(5)	(5)	Common Stock	1.2077	$0	1.2077	D

Explanation of Responses:

1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

2. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

4. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Laurie A. Churchill, Attorney-in-fact	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)